K. Morokuma et al. / Tetrahedron Letters 49 (2008) 6043–6045
6045
6. For related organocatalytic reactions, see (a) Bogevig, A.; Kumaragurubaran, N.;
Jørgensen, K. Chem. Commun. 2002, 620–621; (b) Dambruso, P.; Massi, A.;
Dondoni, A. Org. Lett. 2005, 7, 4657–4660; (c) Tokuda, O.; Kano, T.; Gao, W.-G.;
Ikemoto, T.; Maruoka, K. Org. Lett. 2005, 7, 5103–5105; (d) Tang, Z.; Cun, L.-F.;
Cui, X.; Mi, A.-Q.; Jiang, Y.-Z.; Gong, L.-Z. Org. Lett. 2006, 8, 1263–1266; (e)
Samanta, S.; Zhao, C.-G. J. Am. Chem. Soc. 2006, 128, 7442–7443.
7. For a review, see Saccomano, N. A. In Comprehensive Organic Synthesis; Trost, B.
M., Ed.; Pergamon: Oxford, 1991; Vol. 1, Chapter 1.6.4, pp 193–201.
8. For a review, see Tanaka, F.; Barbas, F. F. In Comprehensive Organic Synthesis;
Dalko, P. I., Ed.; Wiley: Weinheim, 2007; pp 19–55.
9. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J.
Am. Chem. Soc. 1987, 109, 5765–5780.
10. Parikh, J. P.; Doering, W. E. J. Am. Chem. Soc. 1967, 89, 5505–5507.
11. (a) Bal, B. S.; Childers, W. E.; Pinnick, H. W. Tetrahedron 1981, 37, 2091–2096;
(b) Dalcanale, E.; Montanari, F. J. Org. Chem. 1986, 51, 567–569.
accomplished from (2S,3S)-diester 9 as illustrated in Scheme 3.
Thus, 9 was first converted to aldehydes 4 by silylation followed
by oxidative cleavage of the olefinic double bound. Upon reaction
of 4 with triflate 3 in the presence of 4 equiv of CrCl2 and 0.1 equiv
of NiCl2 in DMF at room temperature, the coupling reaction oc-
curred very cleanly to produce alcohol 5 in good yield. After Swern
oxidation of 5 followed by desilylation, exposure of 22 to 3 M
HClO4 in THF at room temperature promoted spiroacetalization
to give spiroacetal 23 as a diastereoisomeric mixture in good yield.
In this case, the C6 spirocenter was preferentially formed in S con-
figuration (dr = 4:1).18 Upon acetylation and oxidative removal of
the p-methoxybenzyl protecting group, 23 gave alcohol 24. Finally,
(+)-trachyspic acid (1)19 was successfully obtained from 24 by
four-step sequence involving Dess–Martin oxidation, Pinnick oxi-
dation, ozonolysis, and treatment with TFA. The specific rotation
and spectroscopic properties (1H and 13C NMR) were in good
agreement with those of natural trachyspic acid.
12. Santini, C.; Ball, R. G.; Berger, G. D. J. Org. Chem. 1994, 59, 2261–2266.
13. ½ ꢁ
a 2D5 +10.5 (c 0.780, CHCl3) (88% ee); 1H NMR (300 MHz, CDCl3) d 1.44 (s, 9H),
1.45 (s, 9H), 1.93 (dt, J = 13.2, 6.2 Hz, 1H), 2.08 (m, 1H), 2.17 (dt, J = 13.5, 6.6 Hz,
1H), 2.46 (ddd, J = 6.7, 12.0, 15.0 Hz, 1H), 2.68 (dd, J = 2.7, 11.7 Hz, 1H), 3.50 (dt,
J = 2.1, 6.3 Hz, 2H), 3.79 (s, 3H), 4.37 (dd, J = 11.4, 13.8 Hz, 2H), 4.49 (dd, J = 1.5,
12.3 Hz, 1H), 5.05 (dd, J = 1.2, 16.8 Hz, 1H), 5.72 (ddt, J = 9.3, 16.5, 6.3 Hz, 1H),
6.85 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3) 28.0,
28.1, 32.2, 37.2, 54.1, 55.3, 65.5, 72.9, 76.6, 81.4, 82.9, 113.8, 116.8, 129.6,
130.2, 135.5, 159.3, 171.7, 173.2; FTIR (neat) 3779, 2712, 3480, 2971, 1722,
1594, 1249, 1157, 840 cmꢂ1; MS (EI) m/z 44, 57, 121 (100), 137, 201, 393, 450
In conclusion, although there still remain the selectivity issues
to be improved in the key organocatalytic aldol reaction, we have
developed a concise enantioselective approach to an alkyl citrate
structure and successfully achieved a total synthesis of (+)-trachy-
spic acid via Cr(II)/Ni(II)-mediated Nozaki–Hiyama–Kishi coupling
of the alkyl citrate moiety and the long chain triflate.
t
(M+); HRMS (EI) calcd for C21H29O5 [(Mꢂ Bu)+]: 393.1913, found, 393.2060.
14. The absolute configuration was deduced from the fact that treatment of 21
with LDA in THF at ꢂ40 °C followed by aq NH4Cl gave 9 and 21 in a ratio of 1:9
in 90% yield. 1H NMR (300 MHz, CDCl3) d 1.41 (18H, s), 1.97 (1H, dt, J = 7.5,
14.1 Hz), 2.13 (1H, ddd, J = 5.7, 7.8, 13.5 Hz), 2.42 (2H, m), 2.66 (1H, dd, J = 4.2,
10.2 Hz), 3.48 (1H, ddd, J = 7.5, 9.0, 16.5 Hz), 3.56 (1H, dt, J = 5.4, 9.0 Hz), 3.78
(3H, s), 4.38 (2H, d, J = 3.3 Hz), 5.00 (1H, d, J = 10.2 Hz), 5.06 (1H, dd, J = 1.2,
16.8 Hz), 5.78 (1H, ddt, J = 7.2, 10.2, 14.1 Hz), 7.23 (2H, d, J = 8.4 Hz); 13C NMR
(75 MHz, CDCl3) d 27.9, 28.1, 31.4, 45.9, 53.0, 55.3, 65.4, 72.8, 76.0, 81.5, 82.6,
113.8, 116.9, 129.5, 130.3, 135.8, 159.2, 172.1, 173.6; FTIR (neat) 3498, 1724,
1573, 1612, 1514, 1458, 1392, 1367, 1248, 1149, 1036 cmꢂ1; HRMS (EI) calcd
for C25H38O7 (M+): 450.2617, found, 450.2625.
Acknowledgment
This work was supported by Grant-in-Aid for Scientific Re-
search on Priority Areas (16073213) from The Ministry of Educa-
tion, Culture, Sports, Science and Technology (MEXT).
15. Hayashi, Y.; Yamaguchi, J.; Hibino, K.; Sumiya, T.; Urushima, T.; Shoji, M.;
Hashizume, D.; Koshino, H. Adv. Synth. Catal. 2004, 346, 1435–1439.
16. Torii, H.; Nakadai, M.; Ishihara, K.; Saito, S.; Yamamoto, H. Angew. Chem., Int. Ed.
2004, 43, 1983–1986.
References and notes
17. Tang, Y.; Cao, C.; Ye, M.; Sun, X. Org. Lett. 2006, 8, 2901–2904.
18. Dehydration of 23 with methanesulfonyl chloride in pyridine afforded the
corresponding diene as a 4:1 epimeric mixture. NOE measurement of this
mixture allowed us to determine the configuration of the C6 spirocenter of the
major isomer to be S.
1. Shiozawa, H.; Takahashi, M.; Takatsu, T.; Kinoshita, T.; Tanzawa, K.; Hosoya, T.;
Furuya, K.; Furihata, K.; Seto, H. J. Antibiot. 1995, 48, 357–369.
2. Hirai, K.; Ooi, H.; Esumi, T.; Iwabuchi, Y.; Hatakeyama, S. Org. Lett. 2003, 5, 857–
859.
3. (a) Zammit, S. C.; White, J. M.; Rizzacasa, M. A. Org. Biomol. Chem. 2005, 3,
2073–2074; (b) Zammit, S. C.; Fero, V.; Hammond, E.; Rizzacasa, M. A. Org.
Biomol. Chem. 2007, 5, 2826–2834.
4. (a) Esumi, T.; Iwabuchi, Y.; Irie, H.; Hatakeyama, S. Tetrahedron Lett. 1998, 39,
877–880; (b) Morokuma, K.; Takahashi, K.; Ishihara, J.; Hatakeyama, S. Chem.
Commun. 2005, 2265–2267.
5. Amer, M. F. A.; Takahashi, K.; Ishihara, J.; Hatakeyama, S. Heterocycles 2007, 72,
181–185.
19.
½
a 2D7
ꢁ
+4.9 (c 0.94, MeOH) [lit.1 a 2D5 +3.1 (c 1.00, MeOH)]; 1H NMR (500 MHz,
½ ꢁ
DMSO-d6) d 0.84 (t, J = 7.0 Hz, 3H), 1.23 (br s, 12H), 1.38 (m, 2H), 2.02 (t,
J = 8.0 Hz, 2H), 2.34 (m, 2H), 2.67 (d, J = 17.0 Hz, 1H), 2.85 (d, J = 16.5 Hz, 1H),
3.57 (dd, J = 8.0, 11.5 Hz, 1H), 8.44 (s, 1H); 13C NMR (125 MHz, CDCl3) 13.9,
20.4, 22.0, 27.5, 28.6, 28.6, 28.8, 31.2, 37.4, 38.7, 48.4, 86.5, 108.0, 116.7, 170.0,
170.5, 171.3, 174.4, 198.1; FTIR (neat) 3446, 2925, 2858, 2613, 1936, 1722,
1604, 1396, 1223, 1140, 1066, 1003 cmꢂ1
[(M+Na)+], 457 [(M+2Na)+].
; MS (FAB) m/z 41 (100), 435